GALNT7 and colorectal cancer: Supplementary Fig. S11A and S11B demonstrated that GALNT7-Low was significantly associated with shorter RFS in stage II to III colorectal cancers in both the GSE39582 MSI (n = 59; P = 0.0064) and FMU-IHC dMMR/MSI cohorts (n = 37; P = 0.0194).